Brand-name drug
Vyvanse price, strengths & recalls
Brand of lisdexamfetamine (generic)
Pharmacies pay $370.40 for 30 capsules of Vyvanse 10 mg capsule this week, and from $370.28 to $370.75 across its 13 priced strengths and forms. The generic, lisdexamfetamine, costs pharmacies from $74.56. It is in shortage (limited availability). It has 11 recalls on record, none ongoing. Its official label last changed on May 6, 2026.
Limited availabilityBrand- Fair cash price
- $436.46
- Strengths
- 13
- Makers
- 1
- Updated
- Nov 11
Vyvanse price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 10 mg capsule Brand | $12.35 | $370.40 / 30 capsules |
| 20 mg capsule Brand | $12.35 | $370.36 / 30 capsules |
| 30 mg capsule Brand | $12.34 | $370.28 / 30 capsules |
| 40 mg capsule Brand | $12.35 | $370.39 / 30 capsules |
| 50 mg capsule Brand | $12.35 | $370.36 / 30 capsules |
| 60 mg capsule Brand | $12.35 | $370.64 / 30 capsules |
| 70 mg capsule Brand | $12.35 | $370.52 / 30 capsules |
| 10 mg chewable tablet Brand | $12.35 | $370.57 / 30 tablets |
| 20 mg chewable tablet Brand | $12.34 | $370.32 / 30 tablets |
| 30 mg chewable tablet Brand | $12.35 | $370.41 / 30 tablets |
| 40 mg chewable tablet Brand | $12.35 | $370.62 / 30 tablets |
| 50 mg chewable tablet Brand | $12.35 | $370.58 / 30 tablets |
| 60 mg chewable tablet Brand | $12.36 | $370.75 / 30 tablets |
The lowest cost per capsule is 30 mg capsule at $12.34. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Vyvanse vs generic lisdexamfetamine
Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:
| Strength | Brand | Generic | Brand costs |
|---|---|---|---|
| 10 mg capsule | $370.40 | $76.26 | 4.9x |
| 20 mg capsule | $370.36 | $74.56 | 5x |
| 30 mg capsule | $370.28 | $86.54 | 4.3x |
| 40 mg capsule | $370.39 | $79.77 | 4.6x |
| 50 mg capsule | $370.36 | $81.84 | 4.5x |
| 60 mg capsule | $370.64 | $78.15 | 4.7x |
| 70 mg capsule | $370.52 | $78.15 | 4.7x |
| 10 mg chewable tablet | $370.57 | $113.71 | 3.3x |
| 20 mg chewable tablet | $370.32 | $129.67 | 2.9x |
| 30 mg chewable tablet | $370.41 | $116.00 | 3.2x |
| 40 mg chewable tablet | $370.62 | $125.21 | 3x |
| 50 mg chewable tablet | $370.58 | $110.41 | 3.4x |
| 60 mg chewable tablet | $370.75 | $107.29 | 3.5x |
Supply status: shortages & recalls
Shortages
- Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77)
- Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01)Estimated recovery: TBD
- Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01)Estimated recovery: TBD
- Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01)Estimated recovery: TBD
- Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01)Estimated recovery: TBD
- Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77)
- Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77)
- Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77)
- Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77)
- Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77)
- Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77)
- Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01)Estimated recovery: TBD
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 11 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Vyvanse
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use VYVANSE safely and effectively. See full prescribing information for VYVANSE. VYVANSE® (lisdexamfetamine dimesylate) capsules, for oral use, CII VYVANSE® (lisdexamfetamine dimesylate) chewable tablets, for oral use, CII Initial U.S. Approval: 2007
WARNING: ABUSE, MISUSE, AND ADDICTION
VYVANSE has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including VYVANSE, can result in overdose and death [see Overdosage (10)], and this risk is increased with higher doses or unapproved methods of administration, such as snorting or injection.
Before prescribing VYVANSE, assess each patient's risk for abuse, misuse, and addiction. Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug. Throughout VYVANSE treatment, reassess each patient's risk of abuse, misuse, and addiction and frequently monitor for signs and symptoms of abuse, misuse, and addiction [see Warnings and Precautions (5.1), Drug Abuse and Dependence (9.2)].
WARNING: ABUSE, MISUSE, AND ADDICTION
See full prescribing information for complete boxed warning.
VYVANSE has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including VYVANSE, can result in overdose and death (5.1, 9.2, 10):
Before prescribing VYVANSE, assess each patient's risk for abuse, misuse, and addiction.
Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug.
Throughout treatment, reassess each patient's risk and frequently monitor for signs and symptoms of abuse, misuse, and addiction.
Recent major changes (as listed on the label)
Indications and Usage (1) | 09/2025 |
Warnings and Precautions (5.5) | 09/2025 |
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA021977 · Takeda Pharms USA
- First approved
- February 23, 2007 (19 years ago)
- Latest approved change
- April 23, 2026
- Approved label
- PDF, Apr 24, 2026
- Generic makers
- 21 approved generic applications on the market
Vyvanse questions
How much does vyvanse cost without insurance?
Pharmacies pay about $370.40 for 30 capsules of vyvanse 10 mg capsule ($12.35 per capsule). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $436.46. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Vyvanse?
Yes: lisdexamfetamine. Pharmacies pay from $74.56 for it. Compare lisdexamfetamine prices.
Is vyvanse in shortage?
Yes. 108 products are listed as in shortage or being discontinued (limited availability). See which ones.
Has vyvanse been recalled?
11 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the vyvanse label last change?
The official label was last updated on May 6, 2026 (version 81). See what changed.
Talk about vyvanse
No comments yet. Questions, tips, what worked for you - start the conversation.